Status:
COMPLETED
Inspiratory Muscle Training in ME/CFS and COVID-19 Survivors
Lead Sponsor:
York University
Conditions:
Myalgic Encephalomyelitis
Post-acute COVID-19 Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Coronavirus-2019 (COVID-19) is a viral disease leading to respiratory dysfunction, but it may also affect the brain and result in the development of myalgic encephalomyelitis/chronic fatigue syndrome ...
Detailed Description
Approximately 10 women and 10 men between the ages of 18-65 will be tested in each of 3 groups: 1. Control participants will be free of previously diagnosed cardiovascular, metabolic, autonomic, or r...
Eligibility Criteria
Inclusion
- Control participants will be free of previously diagnosed cardiovascular, metabolic, autonomic, or respiratory disease.
- COVID-19 participants will have both an official diagnosis and an official clearance of COVID-19. Patients will have long-haul symptoms for at least 3 months. Patients will be recruited via media, social media and clinical collaborators.
- ME/CFS participants will be recruited via media, social media and clinical collaborators. Only those with mild to moderate symptoms who can complete a 6 minute walk test will be recruited.
Exclusion
- severe symptoms of chronic fatigue syndrome
- inability to stand on a tilt table
- inability to walk for 6 minutes
- previous cardiorespiratory disease (except for COVID long-hauler symptoms and chronic fatigue syndrome itself)
- inability to understand and read English.
Key Trial Info
Start Date :
May 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05196529
Start Date
May 9 2022
End Date
January 31 2023
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
York University
Toronto, Ontario, Canada, M3J1P3